BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25148442)

  • 1. Managing hypertension in patients with chronic kidney disease.
    Zuber K; Gilmartin C; Davis J
    JAAPA; 2014 Sep; 27(9):37-46. PubMed ID: 25148442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension Management in Transition: From CKD to ESRD.
    Valika A; Peixoto AJ
    Adv Chronic Kidney Dis; 2016 Jul; 23(4):255-61. PubMed ID: 27324679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic Issues in treating hypertension in CKD.
    Sica DA
    Adv Chronic Kidney Dis; 2011 Jan; 18(1):42-7. PubMed ID: 21224029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy in hypertension.
    Gorostidi M; de la Sierra A
    Adv Ther; 2013 Apr; 30(4):320-36. PubMed ID: 23553510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD.
    Sinha AD; Agarwal R
    Clin J Am Soc Nephrol; 2019 May; 14(5):757-764. PubMed ID: 30425103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension control in chronic kidney disease: don't miss the forest for the trees.
    Ong HT; Ong LM; Ho JJ
    Med J Malaysia; 2012 Aug; 67(4):359-62. PubMed ID: 23082441
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pharmacology of modern antihypertensive agents and their interaction with alpha-adrenoceptor antagonists.
    Narayan P; Man In't Veld AJ
    Br J Urol; 1998 Mar; 81 Suppl 1():6-16; discussion 64-6. PubMed ID: 9589011
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
    Ku E; McCulloch CE; Vittinghoff E; Lin F; Johansen KL
    J Am Heart Assoc; 2018 Oct; 7(19):e009992. PubMed ID: 30371331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension. Medication update.
    Collard CL
    South Med J; 2001 Nov; 94(11):1065-70. PubMed ID: 11780675
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing hypertension in chronic renal disease.
    Faubert PF; Porush JG
    Geriatrics; 1987 Jan; 42(1):49-51, 55-8. PubMed ID: 2879773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current trends in the therapy for hypertension, 1985.
    Ryan C
    Compr Ther; 1985 Oct; 11(10):22-7. PubMed ID: 2865033
    [No Abstract]   [Full Text] [Related]  

  • 13. Development and trends in the drug treatment of essential hypertension.
    van Zwieten PA
    J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertension in patients with heart failure].
    Takekoshi N; Asaji T; Tada N
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():478-83. PubMed ID: 15171419
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertension--new drug therapies. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure.
    Solomon J
    RN; 1994 Jan; 57(1):26-32; quiz 33. PubMed ID: 7905659
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
    Lin YC; Lin JW; Wu MS; Chen KC; Peng CC; Kang YN
    PLoS One; 2017; 12(12):e0188975. PubMed ID: 29240784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
    JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical trials on protective efficacy of antihypertensive agents for organ damage due to diabetes mellitus complicated with hypertension].
    Higashiura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():623-7. PubMed ID: 15171446
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of antihypertensive drugs on chronic kidney disease: a comprehensive review.
    Ptinopoulou AG; Pikilidou MI; Lasaridis AN
    Hypertens Res; 2013 Feb; 36(2):91-101. PubMed ID: 23051659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment?
    Brown A; Captain B
    Am J Ther; 2011 Nov; 18(6):e244-54. PubMed ID: 21436766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.